Morc3 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of Morc3, a protein involved in chromatin remodeling and gene regulation. Morc3, part of the microrchidia (Morc) family, plays a crucial role in nuclear organization and transcriptional repression. It contains key functional domains, including a GHKL-type ATPase domain, which allows it to interact with chromatin and modulate its structure. Morc3 is involved in regulating gene expression by influencing chromatin compaction, facilitating or restricting access to the DNA for transcription factors and other regulatory proteins. By inhibiting Morc3, these compounds interfere with its ability to control chromatin structure, leading to changes in gene expression and nuclear organization.
The mechanisms by which Morc3 inhibitors function typically involve blocking its ATPase activity or preventing its interaction with chromatin, thus disrupting its role in chromatin remodeling. Some inhibitors may also interfere with its ability to form nuclear foci, structures that Morc3 assembles to coordinate its gene regulatory functions. Researchers use Morc3 inhibitors to explore the role of this protein in gene silencing, nuclear organization, and epigenetic regulation. By inhibiting Morc3, scientists can investigate how chromatin structure influences gene expression and how changes in chromatin remodeling affect cellular processes like DNA repair, replication, and transcriptional regulation. These inhibitors serve as valuable tools for studying the molecular mechanisms that regulate chromatin dynamics and for understanding the broader impact of Morc family proteins on maintaining nuclear architecture and genomic stability.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Another DNA methyltransferase inhibitor that could modify chromatin states and thus influence MORC3's function in gene regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that could impact chromatin structure and gene expression, potentially altering the biological context of MORC3 action. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective HDAC inhibitor which may affect chromatin remodeling and gene regulation processes in which MORC3 is involved. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
An HDAC inhibitor that could indirectly influence MORC3 function by modulating chromatin dynamics and gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
An HDAC inhibitor that may alter the transcriptional regulation landscape, potentially affecting MORC3's role in gene expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that could change chromatin architecture and thus have an indirect impact on MORC3's regulatory functions. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor that could disrupt chromatin structure, potentially influencing MORC3's activity in transcription regulation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that could indirectly affect MORC3 by altering the chromatin state and gene expression patterns. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
An HDAC inhibitor that could affect chromatin structure and thereby modulate the transcriptional regulatory functions of MORC3. | ||||||